SEC Form 4 · accession 0001209191-16-127845
Eiger BioPharmaceuticals, Inc. · EIGR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James P Shaffer
Officer — Chief Business Officer
Period of report
Jun 13, 2016
Accepted (ET)
Jun 14, 2016 · 6:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001305253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 13, 2016 | P | 730 | $22.16 | A | 1,975 | D | |
| Common Stock | Jun 13, 2016 | P | 100 | $22.17 | A | 2,075 | D | |
| Common Stock | Jun 13, 2016 | P | 420 | $22.20 | A | 2,495 | D |
Table II — derivative securities
No Table II lines on this filing.